Signatur Biosciences Analysis: $500K Raised
What is Signatur Biosciences?
Signatur Biosciences develops PCR kits for diagnosing complex diseases by detecting gene expression signatures with standard lab equipment.
Product Features & Capabilities
- Smart PCR kits for detecting complex diseases, integration with standard qPCR machines, ability to analyze multiple RNA biomarkers, simplified workflows for precision diagnostics, technology designed for existing clinical infrastructure.
How much Signatur Biosciences raised
s: - $500,000
August 22, 2022Lead Investor: Y Combinator
Who are the founders of Signatur Biosciences
JG
John Goertz
Co-founder, CSO
CD
Celestin de Wergifosse
Co-founder, CEO
Market Focus
Signatur Biosciences primarily focuses on the biotechnology industry, specifically in the development of diagnostic tools for complex diseases through innovative PCR (Polymerase Chain Reaction) kits that detect gene expression signatures.
Investors
- Myelin VC
- PSR Crypto
- Riceberg Ventures
- Imperial College London
Competitors Overview
The main competitors of Signatur Biosciences in the PCR kits and gene expression diagnostics market include:
- Roche Diagnostics: A leading player in molecular diagnostics, Roche offers a comprehensive range of PCR systems and has a strong distribution network. Their focus on strategic acquisi
See something that needs updating? Suggest edits to this profile.